- Ghazal Nabil, .et al. CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer, Cancers (Basel), 2021, Feb 20;13(4):898 PMID: 33672756
Biological Activity
Momelotinib Mesylate (CYT387 Mesylate) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, appr 10-fold selectivity versus JAK3.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.59 mL | 97.93 mL | 195.86 mL |
0.5 mM | 3.92 mL | 19.59 mL | 39.17 mL |
1 mM | 1.96 mL | 9.79 mL | 19.59 mL |
5 mM | 0.39 mL | 1.96 mL | 3.92 mL |
*The above data is based on the productmolecular weight 510.57. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A21658 |
---|---|
Actions | Inhibitor |
CAS No. | 1056636-07-7 |
Formula | C24H26N6O5S |
M. Wt | 510.57 |
Purity | >98% |
Synonyms | CYT387 (Mesylate), CYT 387, CYT-387 |
SMILES | O=C(C1=CC=C(C2=NC(NC3=CC=C(N4CCOCC4)C=C3)=NC=C2)C=C1)NCC#N.O=S(O)(C)=O |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy Momelotinib Mesylate | Momelotinib Mesylate Supplier | purchase | cost | manufacturer | order | distributor | buy 1056636-07-7| 1056636-07-7 Supplier | purchase 1056636-07-7 | 1056636-07-7 cost | 1056636-07-7 manufacturer | order 1056636-07-7 | 1056636-07-7 distributor